Moleculin Launches Grant-Funded Study of Annamycin for Pancreatic Cancer at UNC-Chapel Hill
Moleculin has initiated a grant-funded preclinical programme at the University of North Carolina at Chapel Hill to evaluate Annamycin in pancreatic cancer, including its use alongside novel therapeutic agents and modalities. Early studies suggest Annamycin may effectively target key drivers of the disease.
Preclinical Research | 15/11/2025 | By Dineshwori
MetP Pharma Announces Preclinical Research Results of semaglutide Development
MetP Pharma has announced its preclinical research results that strongly support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.
Preclinical Research | 09/05/2024 | By Aishwarya | 479
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy